Developer docs
API playgroundTry for free, no card

Search company profiles

Pulse Technologies

Full company profile

uuid000bjf2

Namestring
Pulse Technologies
Legal namestring
Pulse Technologies, Inc.
Company typeenum
Private
Founded yearint
1993
Descriptiontext

Pulse Technologies, Inc. is a Quakertown, Pennsylvania-based advanced contract manufacturer founded in 1993 that specializes in precision components and assemblies for active implantable medical devices — spinal implants, orthopedic implants, cardiac rhythm management devices, neurostimulation electrodes, electrophysiology catheters, cochlear and retinal prostheses — with secondary operations in aerospace & defense and commercial precision parts. The company operates a 70,000 sq ft vertically integrated facility with 100+ CNC machine tools (44 Swiss turning, 32 milling, 15 EDM, 11 laser machines), in-house metrology, and 24/7 'lights out' capacity capable of producing over one million spinal implants annually, supported by ISO 13485:2016, AS9100D, ISO 9001:2015, and FDA 21 CFR 820 quality systems.

The company's differentiator is its proprietary Hierarchical Surface Restructuring (HSR™) platform — a patented femtosecond laser process that creates hierarchical surface topographies yielding >500x surface-area gain, >700x specific capacitance improvement, and order-of-magnitude reductions in impedance without delamination risk. HSR™ variants target titanium (leadless pacemakers), ultrathin/microelectrode arrays (peripheral and central nervous system interfacing), and antibacterial CuO-coated electrodes (infection-resistant implants). Complementary coating technologies include TiN, IrO₂, and platinum-group-metal oxides. Pulse's go-to-market is enterprise direct sales (Stephen Trinter, Director of Global Sales & Marketing) into medical device OEM engineering, quality, and procurement teams, with quote-based pricing, multi-year contracts, dock-to-stock and Kanban supply options, and white-paper / technical-blog demand generation. The company was acquired by Integer Holdings Corporation (NYSE: GRT) in January 2024 for $140 million and now operates as a wholly-owned subsidiary.

Short descriptiontext

Pulse Technologies is a Quakertown, PA-based contract manufacturer founded in 1993 that produces precision components and assemblies for medical device OEMs — including spinal, orthopedic, cardiac rhythm management, and neurostimulation implants — anchored by its proprietary HSR™ femtosecond laser surface technology. Now a wholly-owned subsidiary of Integer Holdings Corporation (NYSE: GRT) following its January 2024 acquisition.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersQuakertown, United States
HQ citystring
Quakertown
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract medical manufacturing, precision machined components, implantable device components, electrode surface modification, surface restructuring technology
Industry2 codes
PRIMARYHLAHAFAC
Cardiac Rhythm Management (Pacemakers, ICDs, CRT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHAFAL
Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Device Contract Manufacturing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Manufacturing Services
TypeProfessional Services
Description

Full-scope contract manufacturing of medical device components and assemblies, including design assistance, prototyping, testing, validation, process development, and production transfer. Revenue generated through long-term manufacturing agreements with medical device OEMs.

pulsetechnologies.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Pricing details1 tier
1Custom contract manufacturing services quoted per project
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing. Customers use the 'Get a Quote' form on the website to initiate pricing discussions.

pulsetechnologies.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Pulse Technologies is an advanced contract manufacturer of medical device components and assemblies, specializing in precision machining (Swiss turning, milling, EDM) and proprietary electrode surface modification technologies — most notably its patented Hierarchical Surface Restructuring (HSR™) femtosecond laser platform — for active implantable devices including spinal, orthopedic, cardiac rhythm management, and neurostimulation products. The company operates a vertically integrated 70,000 sq ft ISO 13485 / AS9100D facility and offers end-to-end services from design assistance and prototyping through production transfer for medical, aerospace and defense, and commercial OEMs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Over 2 orders of magnitude increase in charge storage capacity compared to un-restructured Pt-10Ir electrodes
+5 more records
Product overview1 text field

Pulse Technologies is an advanced technology, engineering and contract manufacturing company founded in 1993, focused exclusively on medical device components and assemblies. The company operates from a 70,000-square-foot facility with 250 employees and 100+ CNC machine tools. Their portfolio consists of three interconnected pillars: (1) Contract Manufacturing Services spanning medical (spinal implants, orthopedic devices, cardiac rhythm management), aerospace & defense, and commercial sectors; (2) Advanced Technology offerings including their core Hierarchical Surface Restructuring (HSR™) platform using femtosecond lasers, which includes variants such as Reactive HSR™, Ultrathin HSR™, and Antibacterial HSR™ Electrodes; and (3) Surface Coating Technologies including Titanium Nitride (TiN), Iridium Oxide (IrO₂), Platinum Group Metal Oxide, and Antibacterial Metal Oxide coatings. Manufacturing capabilities include precision machining (44 Swiss turning, 32 milling, 15 EDM, 11 laser machines), welding & assembly, laser texturing, design/prototyping, materials expertise (titanium, PEEK, cobalt chrome, platinum-iridium), metrology, and quality compliance. The company was acquired by Integer Holdings Corporation in January 2024 for $140 million.

Product and service12 records
1Contract Manufacturing Services
CategoryContract Manufacturing
Description

Full-scope contract manufacturing of medical device components and assemblies including design assistance, prototyping, testing, validation, process development, and production transfer, executed under long-term agreements with medical device OEMs.

2Precision Machining Services
CategoryMachining Services
Description

Precision machining services for medical device components including Swiss turning, milling, and EDM with tolerances up to 0.0002 inch (0.005 mm) and EDM repeatability up to 0.0001 inch, delivered to medical device OEMs.

3Welding and Assembly Services
CategoryManufacturing Capability
Description

Welding and assembly services including laser welding, spot welding, and CNC welding for similar and dissimilar metals, offered as part of device-component manufacturing for medical and aerospace customers.

4Design, Prototyping and Engineering Services
CategoryEngineering Services
Description

Design assistance, concept development, prototyping, testing, characterization, documentation, verification and validation, and manufacturing process development services provided to medical device OEMs as an extension of their engineering teams.

5Laser Texturing Services
CategorySurface Engineering
Description

CNC-controlled laser texturing applied to medical device components to increase metal-to-polymer bond strength by approximately 3x, improving quality and reducing cost in cardio and vascular devices.

6Metrology Services
CategoryQuality / Metrology Services
Description

In-house metrology and testing services using optical comparators, coordinate measuring machines (CMM), vision systems, CT scanners, and customized gauges for medical device inspection and validation.

7Quality and Compliance Services
CategoryQuality / Regulatory Services
Description

Quality and regulatory compliance services compliant with FDA 21 CFR 820 and ISO 13485, including real-time statistical process control, dock-to-stock, and Kanban consignment supply options, supporting medical device OEMs through regulatory and documentation requirements.

8Hierarchical Surface Restructuring (HSR™) Technology
CategorySurface Modification Technology
Description

Patented femtosecond laser electrode surface modification technology offered as a contract service to medical device OEMs, producing hierarchical surface topographies that enhance electrochemical performance for neural stimulation and cardiac rhythm management electrodes.

9Antibacterial HSR™ Electrodes
CategorySurface Modification Technology
Description

Platinum-iridium electrodes treated with HSR™ surface restructuring combined with atomic layer deposited copper oxide (CuO) thin films, providing antibacterial properties effective against E. coli and S. aureus while maintaining electrochemical performance, for neural stimulation and cardiac rhythm management applications.

10Electrode Surface Coating Services
CategorySurface Coating Services
Description

Electrode coating services including Titanium Nitride (TiN) coatings applied via magnetron sputtering (PVD), Iridium Oxide (IrO2) coatings, Platinum Group Metal (PGM) oxide coatings, and Antibacterial Metal Oxide coatings, offered to medical device OEMs for cardiac rhythm management, neurostimulation, and sensing applications.

11Scratch-Free Surface Finishes
CategorySurface Finishing Services
Description

Ultra-precision, uniform scratch-free surface finishing services for medical devices requiring high blood flow, designed to minimize complications such as hemolysis during device operation.

12Custom Implant Alloy Development
CategoryMaterials Engineering
Description

Custom alloy development services for medical implants, tailoring material composition and properties to specific performance and biocompatibility requirements for medical device OEMs.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Cardionomic Inc.
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-05-26
Description

Pulse Technologies' proprietary HSR™ electrode surface treatment technology is integrated into Cardionomic's Cardiac Pulmonary Nerve Stimulation (CPNS) System for treating patients suffering from Acute Decompensated Heart Failure (ADHF). This is a strategic technology partnership where Pulse's HSR technology enables Cardionomic's novel cardiac neuromodulation therapy. HSR provides enhanced charge storage capacity, increased capacitance, and decreased impedance for the electrode components of the cardiac device.

pulsetechnologies.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Large-scale medical device contract manufacturer with vertically integrated capabilities for orthopedic, spinal, and minimally invasive surgical devices — competes for the same OEM contract manufacturing business.

2Orchid Orthopedic Solutions
TypeDirect peer
Description

Orthopedic contract manufacturer producing implants, instruments, and cutting technology — directly comparable in contract manufacturing services for spinal and orthopedic OEMs.

TypeDirect peer
Description

End-to-end medical device contract manufacturer offering precision machining, assembly, and finishing for surgical and implantable devices — directly comparable business model and customer base to Pulse Technologies.

TypeDirect peer
Description

Contract manufacturer specializing in ultra-precision machining and laser processing for medical implants and devices — directly comparable in precision manufacturing for orthopedic, spinal, and cardiovascular OEMs.

TypeBroad incumbent
Description

Public medical device contract manufacturer and Pulse's parent company (NYSE: GRT); operates a much broader portfolio across CRM, neuromodulation, and portable medical solutions — incumbent platform with overlapping capabilities at much larger scale.

TypeDirect peer
Description

Division of Heraeus producing components for implantable medical devices including electrodes and leads for CRM and neurostimulation — direct competitor in surface-modified electrode technologies.

TypeOthers
Description

Provider of primary packaging, delivery systems, and components for injectable and implantable drugs and biologics — adjacent ecosystem participant serving the same medical device and pharmaceutical OEM customers, but not a direct contract manufacturing competitor.

TypeDirect peer
Description

Medical device contract manufacturer specializing in laser micromachining, nitinol processing, and electrode fabrication — direct overlap with Pulse's laser-based HSR™ surface modification and electrode manufacturing for neurostimulation and CRM customers.

TypeDirect peer
Description

Medical device contract manufacturer focused on precision-machined implants, instruments, and orthobiologics delivery — directly comparable in precision machining, spinal/orthopedic implant manufacturing, and regulatory-certified services.

TypeDirect peer
Description

Medical device contract manufacturer with expertise in nitinol, advanced polymers, and implantable components — overlapping capabilities in precision manufacturing for CRM, neurostimulation, and structural heart customers.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pulse Technologies

Medical Device Contract Manufacturingpulsetechnologies.com

Pulse Technologies is a Quakertown, PA-based contract manufacturer founded in 1993 that produces precision components and assemblies for medical device OEMs — including spinal, orthopedic, cardiac rhythm management, and neurostimulation implants — anchored by its proprietary HSR™ femtosecond laser surface technology. Now a wholly-owned subsidiary of Integer Holdings Corporation (NYSE: GRT) following its January 2024 acquisition.

What Pulse Technologies does

Pulse Technologies, Inc. is a Quakertown, Pennsylvania-based advanced contract manufacturer founded in 1993 that specializes in precision components and assemblies for active implantable medical devices — spinal implants, orthopedic implants, cardiac rhythm management devices, neurostimulation electrodes, electrophysiology catheters, cochlear and retinal prostheses — with secondary operations in aerospace & defense and commercial precision parts. The company operates a 70,000 sq ft vertically integrated facility with 100+ CNC machine tools (44 Swiss turning, 32 milling, 15 EDM, 11 laser machines), in-house metrology, and 24/7 'lights out' capacity capable of producing over one million spinal implants annually, supported by ISO 13485:2016, AS9100D, ISO 9001:2015, and FDA 21 CFR 820 quality systems.

The company's differentiator is its proprietary Hierarchical Surface Restructuring (HSR™) platform — a patented femtosecond laser process that creates hierarchical surface topographies yielding >500x surface-area gain, >700x specific capacitance improvement, and order-of-magnitude reductions in impedance without delamination risk. HSR™ variants target titanium (leadless pacemakers), ultrathin/microelectrode arrays (peripheral and central nervous system interfacing), and antibacterial CuO-coated electrodes (infection-resistant implants). Complementary coating technologies include TiN, IrO₂, and platinum-group-metal oxides. Pulse's go-to-market is enterprise direct sales (Stephen Trinter, Director of Global Sales & Marketing) into medical device OEM engineering, quality, and procurement teams, with quote-based pricing, multi-year contracts, dock-to-stock and Kanban supply options, and white-paper / technical-blog demand generation. The company was acquired by Integer Holdings Corporation (NYSE: GRT) in January 2024 for $140 million and now operates as a wholly-owned subsidiary.

Pulse Technologies firmographics

Firmographics
Name
Pulse Technologies
Legal name
Pulse Technologies, Inc.
Website
https://pulsetechnologies.com
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
101–250 employees
Short description
Pulse Technologies is a Quakertown, PA-based contract manufacturer founded in 1993 that produces precision components and assemblies for medical device OEMs — including spinal, orthopedic, cardiac rhythm management, and neurostimulation implants — anchored by its proprietary HSR™ femtosecond laser surface technology. Now a wholly-owned subsidiary of Integer Holdings Corporation (NYSE: GRT) following its January 2024 acquisition.
Ownership category
akta.pro rank

Pulse Technologies industry classification

Industry
Product category
Medical Device Contract Manufacturing
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAFAC
Cardiac Rhythm Management (Pacemakers, ICDs, CRT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHAFAL
Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

Keywords

  • Contract medical manufacturing
  • Precision machined components
  • Implantable device components
  • Electrode surface modification
  • Surface restructuring technology

Where Pulse Technologies is headquartered

Location

Headquarters

HQ city
Quakertown
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Pulse Technologies business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Contract Manufacturing Services: Full-scope contract manufacturing of medical device components and assemblies, including design assistance, prototyping, testing, validation, process development, and production transfer. Revenue generated through long-term manufacturing agreements with medical device OEMs.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom contract manufacturing services quoted per project

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Pulse Technologies product offering

Product offering

Core offering

Pulse Technologies is an advanced contract manufacturer of medical device components and assemblies, specializing in precision machining (Swiss turning, milling, EDM) and proprietary electrode surface modification technologies — most notably its patented Hierarchical Surface Restructuring (HSR™) femtosecond laser platform — for active implantable devices including spinal, orthopedic, cardiac rhythm management, and neurostimulation products. The company operates a vertically integrated 70,000 sq ft ISO 13485 / AS9100D facility and offers end-to-end services from design assistance and prototyping through production transfer for medical, aerospace and defense, and commercial OEMs.

Product overview

Pulse Technologies is an advanced technology, engineering and contract manufacturing company founded in 1993, focused exclusively on medical device components and assemblies. The company operates from a 70,000-square-foot facility with 250 employees and 100+ CNC machine tools. Their portfolio consists of three interconnected pillars: (1) Contract Manufacturing Services spanning medical (spinal implants, orthopedic devices, cardiac rhythm management), aerospace & defense, and commercial sectors; (2) Advanced Technology offerings including their core Hierarchical Surface Restructuring (HSR™) platform using femtosecond lasers, which includes variants such as Reactive HSR™, Ultrathin HSR™, and Antibacterial HSR™ Electrodes; and (3) Surface Coating Technologies including Titanium Nitride (TiN), Iridium Oxide (IrO₂), Platinum Group Metal Oxide, and Antibacterial Metal Oxide coatings. Manufacturing capabilities include precision machining (44 Swiss turning, 32 milling, 15 EDM, 11 laser machines), welding & assembly, laser texturing, design/prototyping, materials expertise (titanium, PEEK, cobalt chrome, platinum-iridium), metrology, and quality compliance. The company was acquired by Integer Holdings Corporation in January 2024 for $140 million.

Differentiator

Problem solved

Functional benefit

Products and services

  • Contract Manufacturing Services Full-scope contract manufacturing of medical device components and assemblies including design assistance, prototyping, testing, validation, process development, and production transfer, executed under long-term agreements with medical device OEMs.
  • Precision Machining Services Precision machining services for medical device components including Swiss turning, milling, and EDM with tolerances up to 0.0002 inch (0.005 mm) and EDM repeatability up to 0.0001 inch, delivered to medical device OEMs.
  • Welding and Assembly Services Welding and assembly services including laser welding, spot welding, and CNC welding for similar and dissimilar metals, offered as part of device-component manufacturing for medical and aerospace customers.
  • Design, Prototyping and Engineering Services Design assistance, concept development, prototyping, testing, characterization, documentation, verification and validation, and manufacturing process development services provided to medical device OEMs as an extension of their engineering teams.
  • Laser Texturing Services CNC-controlled laser texturing applied to medical device components to increase metal-to-polymer bond strength by approximately 3x, improving quality and reducing cost in cardio and vascular devices.
  • Metrology Services In-house metrology and testing services using optical comparators, coordinate measuring machines (CMM), vision systems, CT scanners, and customized gauges for medical device inspection and validation.
  • Quality and Compliance Services Quality and regulatory compliance services compliant with FDA 21 CFR 820 and ISO 13485, including real-time statistical process control, dock-to-stock, and Kanban consignment supply options, supporting medical device OEMs through regulatory and documentation requirements.
  • Hierarchical Surface Restructuring (HSR™) Technology Patented femtosecond laser electrode surface modification technology offered as a contract service to medical device OEMs, producing hierarchical surface topographies that enhance electrochemical performance for neural stimulation and cardiac rhythm management electrodes.
  • Antibacterial HSR™ Electrodes Platinum-iridium electrodes treated with HSR™ surface restructuring combined with atomic layer deposited copper oxide (CuO) thin films, providing antibacterial properties effective against E. coli and S. aureus while maintaining electrochemical performance, for neural stimulation and cardiac rhythm management applications.
  • Electrode Surface Coating Services Electrode coating services including Titanium Nitride (TiN) coatings applied via magnetron sputtering (PVD), Iridium Oxide (IrO2) coatings, Platinum Group Metal (PGM) oxide coatings, and Antibacterial Metal Oxide coatings, offered to medical device OEMs for cardiac rhythm management, neurostimulation, and sensing applications.
  • Scratch-Free Surface Finishes Ultra-precision, uniform scratch-free surface finishing services for medical devices requiring high blood flow, designed to minimize complications such as hemolysis during device operation.
  • Custom Implant Alloy Development Custom alloy development services for medical implants, tailoring material composition and properties to specific performance and biocompatibility requirements for medical device OEMs.

Quantifiable outcome

  • Over 2 orders of magnitude increase in charge storage capacity compared to un-restructured Pt-10Ir electrodes
  • +5 more outcomes

Companies that use Pulse Technologies

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Pulse Technologies technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature10 records

Pulse Technologies partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Cardionomic Inc.coreStrategic or Co-development Partner · 26 May 2022Pulse Technologies' proprietary HSR™ electrode surface treatment technology is integrated into Cardionomic's Cardiac Pulmonary Nerve Stimulation (CPNS) System for treating patients suffering from Acute Decompensated Heart Failure (ADHF). This is a strategic technology partnership where Pulse's HSR technology enables Cardionomic's novel cardiac neuromodulation therapy. HSR provides enhanced charge storage capacity, increased capacitance, and decreased impedance for the electrode components of the cardiac device.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Pulse Technologies competitors and assessment

Company assessment

Direct peers

  • Viant Medical: Large-scale medical device contract manufacturer with vertically integrated capabilities for orthopedic, spinal, and minimally invasive surgical devices — competes for the same OEM contract manufacturing business.
  • Orchid Orthopedic Solutions: Orthopedic contract manufacturer producing implants, instruments, and cutting technology — directly comparable in contract manufacturing services for spinal and orthopedic OEMs.
  • Tegra Medical: End-to-end medical device contract manufacturer offering precision machining, assembly, and finishing for surgical and implantable devices — directly comparable business model and customer base to Pulse Technologies.
  • Norman Noble: Contract manufacturer specializing in ultra-precision machining and laser processing for medical implants and devices — directly comparable in precision manufacturing for orthopedic, spinal, and cardiovascular OEMs.
  • Heraeus Medical Components: Division of Heraeus producing components for implantable medical devices including electrodes and leads for CRM and neurostimulation — direct competitor in surface-modified electrode technologies.
  • Resonetics: Medical device contract manufacturer specializing in laser micromachining, nitinol processing, and electrode fabrication — direct overlap with Pulse's laser-based HSR™ surface modification and electrode manufacturing for neurostimulation and CRM customers.
  • Avalign Technologies: Medical device contract manufacturer focused on precision-machined implants, instruments, and orthobiologics delivery — directly comparable in precision machining, spinal/orthopedic implant manufacturing, and regulatory-certified services.
  • Confluent Medical Technologies: Medical device contract manufacturer with expertise in nitinol, advanced polymers, and implantable components — overlapping capabilities in precision manufacturing for CRM, neurostimulation, and structural heart customers.

Broad incumbents

  • Integer Holdings Corporation: Public medical device contract manufacturer and Pulse's parent company (NYSE: GRT); operates a much broader portfolio across CRM, neuromodulation, and portable medical solutions — incumbent platform with overlapping capabilities at much larger scale.

Others

  • West Pharmaceutical Services: Provider of primary packaging, delivery systems, and components for injectable and implantable drugs and biologics — adjacent ecosystem participant serving the same medical device and pharmaceutical OEM customers, but not a direct contract manufacturing competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Pulse Technologies social profiles

Digital presence

Pulse Technologies compliance and trust

Trust signal

Compliance5 records

Pulse Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pulse Technologies leadership team

Management profile

Number of profiles

Profiles3 records

Pulse Technologies funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pulse Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pulse Technologies

What does Pulse Technologies do?

Pulse Technologies is an advanced contract manufacturer of medical device components and assemblies, specializing in precision machining (Swiss turning, milling, EDM) and proprietary electrode surface modification technologies — most notably its patented Hierarchical Surface Restructuring (HSR™) femtosecond laser platform — for active implantable devices including spinal, orthopedic, cardiac rhythm management, and neurostimulation products. The company operates a vertically integrated 70,000 sq ft ISO 13485 / AS9100D facility and offers end-to-end services from design assistance and prototyping through production transfer for medical, aerospace and defense, and commercial OEMs.

Is Pulse Technologies a public or private company?

Pulse Technologies is a private company. It is classified as corporate owned and is currently operating.

When was Pulse Technologies founded?

Pulse Technologies was founded in 1993. It employs 101 to 250 people.

Where is Pulse Technologies based?

Pulse Technologies is headquartered in Quakertown, United States, in the North America region.

How does Pulse Technologies make money?

One revenue line is on record: contract Manufacturing Services.

Who are Pulse Technologies's main competitors?

Direct peers on record are Viant Medical, Orchid Orthopedic Solutions, Tegra Medical, Norman Noble, Heraeus Medical Components, Resonetics, Avalign Technologies and Confluent Medical Technologies. Integer Holdings Corporation is listed as a broad incumbent. West Pharmaceutical Services is listed as an others.

Does Pulse Technologies have an API?

No public API is recorded for Pulse Technologies.

What industry is Pulse Technologies in?

Pulse Technologies's product category is Medical Device Contract Manufacturing. Its primary akta.pro industry code is HLAHAFAC, Cardiac Rhythm Management (Pacemakers, ICDs, CRT), with a secondary code of HLAHAFAL, Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireMedical Device Contract Manufacturing Market to Value USD 268.6 Billion by 2035, Growing at an 11.89% CAGR – SNS InsiderSNS Insider released a market research report projecting the global medical device contract manufacturing market to grow from USD 87.32 billion in 2025 to USD 268.6 billion by 2035, expanding at an 11.89% CAGR, driven by increasing OEM outsourcing, stringent regulations, and adoption of advanced manufacturing technologies including robotics, AI, and additive manufacturing. Asia Pacific led regional revenue in 2025 with a 38.7% share, while North America emerged as the fastest-growing market. Recent notable acquisitions in the sector include Arterex Medical Solutions' purchase of Phoenix S.r.l. and Integer Holdings Corporation's acquisition of Pulse Technologies for USD 140 million.openPR.comGlobal Factors Influencing the Rapid Evolution of the Robotic Welding Market in Automotive ManufacturingThe Business Research Company released a market report projecting the robotic welding market for automotive manufacturing to reach $5.9 billion by 2030, driven by electric vehicle production and smart factory automation. The article also details the micromachining market landscape, highlighting key players such as IPG Photonics and TRUMPF Group, and noting Integer's acquisition of Pulse Technologies. These reports provide segmentation data and trend analysis for industrial manufacturing sectors.openPR.comMedTech CMO Market Trends Shaped by Regulatory Compliance and End-to-End Manufacturing SolutionsInsightAce Analytic released a market assessment report projecting the Global MedTech CMO Market to grow at a 12.5% CAGR during 2026 to 2035, driven by increasing OEM outsourcing trends and rising demand for cost-effective medical devices. Two notable recent developments were reported: Nipro Medical Corporation established its first North American manufacturing facility in Greenville, North Carolina in July 2024, and Integer Holdings Corporation acquired Pulse Technologies for $140 million in January 2024 to expand its medical device contract manufacturing capabilities.GlobeNewswireInteger to Showcase Strategic Investments to Support Customers’ Growth and Innovation at Heart Rhythm 2024Integer Holdings will exhibit at Heart Rhythm 2024 in Boston from May 16-19, showcasing its end-to-end medical device solutions. The company highlighted its acquisition of Pulse Technologies, which adds precision machining and HSR coatings to its portfolio. These investments aim to shorten time to market and enhance patient care.Business InsiderInteger to Showcase Strategic Investments to Support Customers’ Growth and Innovation at Heart Rhythm 2024Integer Holdings will exhibit at Heart Rhythm 2024 in Boston from May 16-19, showcasing its end-to-end medical device solutions. The company highlighted its acquisition of Pulse Technologies, which adds precision machining and HSR coating technologies to its portfolio. These investments aim to shorten time to market and enhance patient care.GlobeNewswireInteger to Showcase Recently Acquired Capabilities and New Technologies at MD&M West 2024Integer Holdings will exhibit at MD&M West 2024 in Anaheim, showcasing its medical device manufacturing capabilities and recent acquisitions of InNeuroCo and Pulse Technologies. The exhibit highlights neurovascular solutions, precision micro machining, and product areas including cardiac rhythm management and cardiovascular solutions.Cardiovascular BusinessInteger acquires medical device specialists with experience in structural heart, electrophysiology for $140MInteger Holdings Corp. has finalized the acquisition of Pulse Technologies, a Pennsylvania-based medical device contract manufacturer, for approximately $140 million. The deal aims to expand Integer's capabilities in structural heart and electrophysiology markets, adding Pulse's specialized materials and coatings expertise to its portfolio. The purchase price may increase over the next two years based on specific revenue growth targets.G-MedtechInteger Acquires Pulse Technologies for $140MInteger Holdings has acquired Pulse Technologies, a privately held technology and engineering firm, for approximately $140 million. This transaction supports Integer's strategic objective to expand its capabilities in high-growth medical device markets, specifically targeting structural heart and neuromodulation sectors. Pulse Technologies, which generated an estimated $42 million in revenue in 2023, brings proprietary surface finishing technologies to the acquisition.Mpo-magInteger Buys Pulse Technologies for $140MInteger Holdings has acquired privately-held Pulse Technologies for $140 million to expand its end-to-end development capabilities and manufacturing footprint in targeted growth markets. The acquisition adds Pulse's proprietary technologies and approximately 250 employees to Integer, which also reported preliminary full-year 2023 sales of $1.595-$1.597 billion, representing a 16% increase.GlobeNewswireInteger Holdings Corporation Announces Preliminary Unaudited Sales Results and Acquisition of Pulse TechnologiesInteger Holdings Corporation announced preliminary unaudited full-year 2023 sales of $1.595–$1.597 billion, reflecting a 16% increase over 2022, and completed the acquisition of Pulse Technologies for approximately $140 million. The acquisition adds micro-machining capabilities in high-growth medical device markets to Integer's portfolio. Integer plans to release its fourth-quarter and full-year earnings results on February 15, 2024.